Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BOARDS2: Glaucoma > OHTN > Flashcards

OHTN Flashcards

1
Q

OHTN

A

Statistically elevated IOP in the presence of an open angle on gonio and healthy optic nerves. The OHTS defined OHTN as an IOP 24-32mmHg. Clinically it is often classified as an IOP >22mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

OHTS study

A

Included patients with elevated IOP 24-32 with an open angle on gonio, a healthy ONH, and no VF defects

  • patients were randomized into a treatment group (drops), and a control group. The target IOP for patietns in the treatment group was at least a 20% IPO reduction from baseline IOP and an IOP <24mmHg
  • patients were followed for 5 years. The primary endpoint was progression to POAG, defined as glaucomatous damage to the ONH, glaucomatous VF defects or both

After 5 years, 9.6% of patients in the control group progressed to POAG, compared to 4.4% in the treatment group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Average CCT

A

473-597

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the clinical average of CCT considered

A

555

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Thicker CCT gives an ______ of IOP readings

A

Overestimation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Thinner CCTs give an _____ of IOP readings

A

Underestimation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CCT and glaucoma risk

A

OHTS concluded that thin pachs are an independent risk factors for he progression to POAG, even after controlling for the effect of CCT on IOP and other risk factors. Recall that it is no longer recommended to use a correction factor to determine the true IOP based on CCT, as the various proposed correction factors are unreliable; CCT should only be used to assign risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

High risk CCTs

A

<555

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

No change in risk on CCTs

A

555-588

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lower risk of POAG progression with CCTs

A

> 588

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

POAG risk: race

A

AA (as well as Hispanics and Latinos) have an increased prevalence compared to Europeans and caucasians

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

POAG and famHx

A

Positive famHx of POAG (first degree relative) increases the risk development of POAG by 3-4x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most important risk factor of progression to POAG

A

Elevated IOP

  • the only risk factor that can be treated
  • as IOP increases, the risk of POAG also increases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Baltimore eye study

A

Followed patients with OHTN without treatment for 40 months and noted that 2.7% of patietns with an IOP 21-25mmHg, 12% of patients with an IOP 26-30mmHg, and 41.2% of patients with IOP >30mmHg developed POAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Age of 90% of patients with POAG

A

> 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Other potential risks for POAG

A

History of blunt trauma
Chronic use of systemic or topical ophthalmic steroids
Possibly myopia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

P value of >5% on OCT

A

A p value >5% is assocaited with sectors marked as green on an OCT and indicates the thickness value is within the normal range for 95% of healthy patients in the population. A yellow sector is associated with a p value <5% but >1% and indicates the thickness value is normal for 1-5% of healthy patients in the population. A red sector is associated with a p value of <1% and indicates the thickness value is normal for less than 1% of the healthy patients in a population

18
Q

Looking at red and yellow sectors on RNFL

A

Does not indicate that the patient has glaucoma. It indicates that the thickness value is normal in few healthy patients in the population. Always look at the optoc nerve rim tissue and the VF in addition to the OCT prior to making the diagnosis of glaucoma

19
Q

HRT

A

Uses confocal scanning laser tomography to obtain a 3d image of the optic disc and the retina

20
Q

GDx

A

Uses scanning laser polarimetry to measure the RNFL thickness

21
Q

OCT

A

Uses optical coherence tomography to measure the RNFL thickness and macualr thickness

22
Q

TSNIT pattern

A

Shows the RNFL thickness around the optic nerve. A normal TSNIT will have a double hump pattern, the shaded are of the map represents the range of the normative database

23
Q

What quadrants are most important to look at on scans for glaucoma

A

S and I

24
Q

ALT vs SLT

A
  • ALT uses argon laser (same as PRP); SLT uses a selective frequency doubled Nd:YAG laser
  • both ALT and SLT apply laser to the TM in order to lower IOP, although their proposed mechanisms differ: ALT causes scarring of the TM, causing tissue contraction that opens up the surrounding pores of the TM to improve AH outflow
  • SLT stimulates the endothelial cell pumps and macrophages withi nthe TM to remove debris, resulting in an increase in AH outflow
  • both have similar long term efficacy at controlling IOP, as well as similar side effects
  • advantage of SLT of ALT is the repeatability of SLT due to reduced thermal damage to the TM compared to ALT
25
Q

How does NTG differ from other glaucoma

A
  • japanese
  • IOP <24 (or less than 21)
  • more likely to get a France hemorrhage
  • paracentral VF defect
  • progresses much slower, if at all
  • much different risk factors and include vascular disorders (raynauds, sleep apnea)
26
Q

IOP and NTG

A 
Plays less of a role here than in POAG
Other risks
-vascular conditions
-low blood pressure
-sleep apnea 
-hypercoagulation
27
Q

Most common VF defect in NTG

A

Paracentral

28
Q

Optic neuropathy and NTG

A

Since IOP is in the normal range in NTG, it is important to consider other possible causes of optic neuropathy, especially in cases of suspected unilateral NTG. Additionally causes include hemorrhagic shock, MI, anemia, syphilis, vasculitis

29
Q

Study question of OHTS

A

Does treating elevated IOP in a patient with OHTN decrease risk of progressing to POAG

30
Q

Conclusion of OHTS

A

Treating patients with OHTN reduces the risk of progression to POAG by 5%

  • the benefit of treatment is likely over-stated, as all patients who progressed to POAG based on glaucomatous optic nerve changes alone were asymptomatic, and even those patients that progressed based on VF defects were likely still asymptomatic
  • certain patietns may have a higher rusk of progressing to POAG based on multiple risk factors. The decision to treat an individual patient with OHTN is multi-factorial; not all patients with OHTN require treatment. VF defects should be confirmed with consecutive fields to ensure true progression to POAG
31
Q

EGPS study question

A

Does lowering IOP in patients with OHTN decreased the rare of progression to POAG

32
Q

Conclusion of EGPS

A

Treatment of OHTN does not reduce the risk of progression to POAG. However, note that this study is poorly designed compared to the OHTS, as there was a high drop out rate, patients had thicker than average CCTs, only one IOP drop was used and no target IOP was set

33
Q

EMGT study question

A

Should patients with newly diagnosed glaucoma be treated with IOP lowering drugs

34
Q

Results of EMGT

A

45% of patients in the treatment group progressed compared to 62% on the control group

35
Q

Risk factors to progression based on EMGT

A

Higher IOP (baseline and after treatment), bilateral disease, PXF, older age, and disc hemorrhages. For every 1mmHg of lowered IOP, there was a 10% reduction in risk of progression

36
Q

Conclusion of EMGT

A

Lowering IOP reduces the risk of progression in the patients with early glaucoma. However almost half of the treated patients still progressed

37
Q

CIGTS study question

A

Should patients with early (asymtaotmic) glaucoma (including pigmetnary and PXF) be initally treated with trab or with drops

38
Q

Conclusion of CIGTS

A

Trab and drops are equally effective in the treatment of early OAG. Both should be soldiered as inital treatment options, although drops are often recommended first due to quality of life issues and lower risk of ocular complications, including cataracts

39
Q

CNTGS study question

A

Does lowering IOP reduce the rate of progression in NTG

40
Q

Conclusion of CNGTS

A

Treament is effective at reducing the risk of pression to NTG, but 2/3 of patietns with non fixation threatened NTG will not progress, even without treatment

41
Q

AGIS study question

A

Should patients with advances glaucoma and inadequate IOP control on max therapy be treated with trab or ALT first

42
Q

Conclusion of AGIS

A

The lower the IOP, the less risk of VF progression; a less important (but often quoted) conclusion is that ATT resulted in less VA loss in AA and TAT resulted in less VF loss in caucasians, however, the risk benefit ratio of each treatment should be considered for every patient, regardless of race

BOARDS2: Glaucoma (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions